Rankings / Immune & Inflammation
Probiotics (multi-strain)
Immune & Inflammation · Live microbial supplement
Tier A
Bottom line
Read Off Label grades Probiotics (multi-strain) as A (8.0/10) based on strong evidence, variable benefit magnitude, and a low-risk safety profile.
Strain specificity matters more than total CFU — marketing 'bigger number' is often irrelevant.
Studied, labeled, or reported-use context: Strain- and dose-specific; typical 10-50 billion CFU/day — OTC; not individualized guidance.
If you were testing this on yourself
Two properties decide whether an n-of-1 experiment is readable and recoverable. These describe the experiment — they are not a judgment about whether to run it, and nothing here is a recommendation.
Can you undo it?
Reverses on stopping
Most strains do not durably colonise; effects fade within weeks of stopping. That is a limitation for benefit and a reassurance for risk.
Can you tell if it worked?
Readable — 2–4 weeks
Symptom diary — stool form, bloating, urgency. Nothing systemic you can measure at home.
What would fool you Effects are strain-specific, so a null result tells you about the product you tried and not about probiotics. GI symptoms fluctuate with diet, stress, and sleep enough to swamp a modest effect unless you track for several weeks.
Citation correction in progress
1 PubMed link was found to be unrelated to this entry and removed from public output. The remaining sources are shown below, but this row's claims and score still need a full source-by-source revalidation.
What the evidence says
Strain specificity matters more than total CFU — marketing 'bigger number' is often irrelevant. Suez 2018 showed probiotic colonization is highly individual; post-antibiotic probiotics may actually delay native microbiome recovery vs no intervention. Focus on strain-indication matches (e.g., VSL#3 for pouchitis, LGG for AAD).
Mechanism
Live bacteria (Lactobacillus, Bifidobacterium, Streptococcus thermophilus, etc.) colonize transiently and modulate luminal microbiome, immune signaling, and gut barrier; strain-specific effects
Studied, labeled, or reported dose & route
Strain- and dose-specific; typical 10-50 billion CFU/day
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Probiotics (multi-strain)'s effects?
- Read Off Label rates the evidence for Probiotics (multi-strain) as Strong and the benefit magnitude as variable, producing an overall grade of A (8.0/10). Strain specificity matters more than total CFU — marketing 'bigger number' is often irrelevant.
- What safety findings are reported for Probiotics (multi-strain)?
- Probiotics (multi-strain) has a low risk profile in the database. Low (translocation/bacteremia risk in immunocompromised or central-line patients — case reports) Legal status: OTC.
- What doses or routes are reported for Probiotics (multi-strain)?
- Strain- and dose-specific; typical 10-50 billion CFU/day This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Probiotics (multi-strain) work?
- Live bacteria (Lactobacillus, Bifidobacterium, Streptococcus thermophilus, etc.) colonize transiently and modulate luminal microbiome, immune signaling, and gut barrier; strain-specific effects
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.